Nachrichten zur Pfizer Inc. Aktie

Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis

Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Should you chase high yields…

Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis @themotleyfool #stocks $PLD $PFE $AMZN $FDX $HD $MCO $SPGI $BMY $BBIO

…

Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer

StoneCo, Centene, CVS, and Pfizer stand out as top value picks with strong cash flow amid market uncertainty.…

Pfizer Market-Perform

NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Pfizer mit einem Kursziel von 30 US-Dollar…

Bernstein belässt Pfizer auf Market-Perform - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Pfizer mit einem Kursziel von 30 US-Dollar…

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.…

Pfizer: I Should Have Sold Earlier (Downgrade)

…

Pfizers R&D Optimization Delivers Great Results & Secure Dividends

…

Pfizer Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer anlässlich der Asco-Krebsforschertagung mit einem Kursziel von…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer anlässlich der Asco-Krebsforschertagung mit einem Kursziel von…

Addiction Disorders Drugs Market Analysis and Forecast to 2030: A $39.5 Billion Opportunity Led by Pfizer, Johnson & Johnson, and Indivior

Dublin, June 02, 2025 (GLOBE NEWSWIRE) -- The "Addiction Disorders Drugs Market by Indication, Product Type, Route of…

Terrible News for Pfizer Stock Investors

The past three years have been challenging for Pfizer (NYSE: PFE). Revenue and earnings have moved in the wrong direction,…

Arvinas and Pfizers Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer

NEW HAVEN, Conn. and NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE:…

Pfizer (PFE) Down 5% Since Last Earnings Report: Can It Rebound?

Pfizer (PFE) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Pfizer Hold

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer von 28 auf 25 US-Dollar gesenkt und die…

Berenberg senkt Ziel für Pfizer auf 25 Dollar - Hold

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer von 28 auf 25 US-Dollar gesenkt und die…

Unlocking Pfizers Value: Cost Controls And Oncology Pipeline

…

Is Pfizer Stock a Buy After This $1.25 Billion Investment?

Pfizer (NYSE: PFE) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first…

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

Qatar Dietary Supplements Market Forecast Report 2025-2030 | Rising Demand for Preventive Healthcare Spurs Growth in Qatars Supplement Sector - A $70.48 Million Market by 2030

The Qatar Dietary Supplements Market is set to grow from USD 48.19 Million in 2024 to USD 70.48 Million by…

Investing In The Promising PD1/VEGF Bispecific; Pfizer And Instil Could Be Good Candidates

Bispecific anti-PD1/VEGF remains one of the hottest topics in the oncology field. Click here for a detailed analysis.…

Down 63%, Should You Buy the Dip on Pfizer?

Pfizer has taken its lumps lately. Its time to wonder whether the stock can make a comeback.…

Pfizer Stock Analysis: Buy, Sell, or Hold?

Pfizers (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst team just…

Pfizer bid to expand Talzenna use in prostate cancer questioned by FDA panel

…

Pfizer Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Pfizer angesichts der Lizenzierung eines Krebsmedikaments aus China…

Jefferies hebt Ziel für Pfizer auf 33 Dollar - Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Pfizer angesichts der Lizenzierung eines Krebsmedikaments aus China…

The Zacks Analyst Blog Highlights Pfizer, Coca-Cola and The Walt Disney

Pfizer, Coca-Cola and The Walt Disney are part of the Zacks top Analyst Blog.…

2 High-Yield Dividend Stocks to Buy Right Now

Though there are plenty of dividend stocks on the market, they arent all created equal. Consider that the average dividend…

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Resilient and growing. Those two descriptions definitely apply to the healthcare sector. People need healthcare products and services regardless of…

MRNA, PFE Stocks Jump Despite FDAs Stricter Standards for COVID-19 Shots

Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer and…

Pfizer Aktie steigt um 2% - 1,25 Mrd. USD Deal mit 3SBio für Krebs-Therapie

Frankfurt (www.aktiencheck.de) - Pfizer-Aktienanalyse von XTB: Die Experten von XTB nehmen die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol:…

Jefferies belässt Biontech auf Buy - Ziel 149 Dollar

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Biontech auf "Buy" mit einem Kursziel von 149 US-Dollar belassen. Die…

Pfizer Thinks Bigger With 3SBio Deal

…

Pfizer Signs Experimental Drug Licensing Agreement With 3SBio

Pfizer inks Experimental Drug Licensing Deal With China-based company 3SBio.…

Pfizer signs $6bn licensing deal with China’s 3SBio for cancer drug

Pfizer Inc (NYSE:PFE, ETR:PFE) has agreed a licensing deal worth up to $6 billion with Chinese biopharmaceutical group 3SBio to develop…

These 3 Dividend Stocks Yield More Than 6% and Their Payouts Look Safe

If you see a stock that pays 6% in dividends, you might assume its too risky -- but thats not…

Pfizer Aktienanalyse: 3SBio-Deal, Q1 2025 Zahlen & Analystenkommentare

Bad Marienberg (www.aktiencheck.de) - Pfizer Aktienanalyse: 3SBio-Deal, Q1 2025 Zahlen & Analystenkommentare Pfizer Aktienanalyse: Milliarden-Deal mit 3SBio & solide…

Pfizer: Auf den Spuren von BioNTech – Milliarden-Deal!

Der Pharma-Riese Pfizer stärkt erneut sein Entwicklungsportfolio. Die US-Amerikaner sind dieses Mal in China fündig geworden und haben einen milliardenschweren…

Pfizer signs up to $6 billion licensing deal with Chinas 3SBio for cancer drug

Pfizer has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc for the…

Pfizer signs up to $6 billion licensing deal with China’s 3SBio for cancer drug By Reuters

Pfizer signs up to $6 billion licensing deal with China’s 3SBio for cancer drug…

Pfizers Turnaround Story Is Stronger Than You Think

…

Heres How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income @themotleyfool #stocks $PFE

…

US House panel seeks information from Pfizer over alleged COVID vaccine delay By Reuters

US House panel seeks information from Pfizer over alleged COVID vaccine delay…

Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer

StoneCo, Centene, CVS Health and Pfizer have been highlighted in this Screen of The Week article.…

ROUNDUP/SMS an Pfizer: Von der Leyen kassiert Schlappe vor Gericht

LUXEMBURG (dpa-AFX) - Die "New York Times" hat im Rechtsstreit um die Herausgabe von SMS von…

ROUNDUP/SMS an Pfizer: Von der Leyen kassiert Schlappe vor Gericht

LUXEMBURG (dpa-AFX) - Die "New York Times" hat im Rechtsstreit um die Herausgabe von SMS von EU-Kommissionspräsidentin Ursula von der…

POLITIK: Schlappe für von der Leyen im Prozess um SMS an Pfizer-Chef

LUXEMBURG (dpa-AFX) - Im Rechtsstreit um Textnachrichten an einen Pharma-Konzernchef hat EU-Kommissionspräsidentin Ursula von der Leyen…

Urteil zu von der Leyens SMS an Pfizer-Chef erwartet

LUXEMBURG (dpa-AFX) - Das Gericht der EU urteilt am Mittwoch zur Herausgabe der SMS-Nachrichten von EU-Kommissionspräsidentin Ursula von der Leyen…

Should Value Investors Buy Pfizer (PFE) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen

J&J, Eli Lilly, Pfizer, Merck, Amgen are included in this Analyst Blog.…